Vycor Medical, Inc.
VYCO
$0.07
$0.00-0.29%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.80K | -72.50K | -16.50K | -81.20K | -115.10K |
| Total Depreciation and Amortization | 62.70K | 63.10K | 63.90K | 63.70K | 64.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.30K | 52.20K | 70.30K | 60.00K | 41.50K |
| Change in Net Operating Assets | 20.70K | -56.30K | -208.60K | -50.50K | 40.60K |
| Cash from Operations | 112.80K | -13.50K | -91.00K | -8.10K | 31.30K |
| Capital Expenditure | -5.20K | -5.20K | -3.60K | -9.00K | -5.40K |
| Sale of Property, Plant, and Equipment | 2.90K | 800.00 | 1.00K | 1.30K | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.30K | -4.40K | -2.60K | -7.60K | -4.80K |
| Total Debt Issued | 59.00K | 59.00K | 59.00K | 61.00K | 61.00K |
| Total Debt Repaid | -57.10K | -59.90K | -58.90K | -64.90K | -70.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.00K | -800.00 | 200.00 | -3.90K | -9.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.70K | -18.60K | -93.40K | -19.60K | 17.10K |